Ketogenic Therapy as an Adjuvant for Malignant Glioma: Impacts on Anti-Tumor Immunity
abstract: Malignant brain tumors are devastating despite aggressive treatments such as surgical resection, chemotherapy and radiation therapy. The average life expectancy of patients with newly diagnosed glioblastoma is approximately 15 months. One novel therapeutic strategy involves using a ketogen...
Other Authors: | Woolf, Eric Christopher (Author) |
---|---|
Format: | Doctoral Thesis |
Language: | English |
Published: |
2018
|
Subjects: | |
Online Access: | http://hdl.handle.net/2286/R.I.50100 |
Similar Items
-
CRKL Is an Important Regulator of PI3K Signaling in PTEN-Deficient Tumors
by: Zhang, Jing
Published: (2013) -
Characterizing Tumor Hypoxia and Anoikis Resistance in Human Osteosarcoma| Addressing Critical Aspects of Disease Progression
by: Scholten II, Donald Jay
Published: (2017) -
Regulation and action of SKP2 and RhoA in cell and tumor models: Investigation into the molecular mechanisms responsible for the aggressive phenotype of triple-negative breast cancer
by: Fagan-Solis, Katerina D
Published: (2013) -
Translational Reprogramming by eIF4E in Tamoxifen-Resistant ER+ Breast Cancer
by: Geter, Phillip A.
Published: (2018) -
The Role of Hyperinsulinemia in Breast Cancer Progression
by: Zelenko, Zara
Published: (2016)